Free Trial
LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 678 +4.00 (+0.59%)
(As of 11/21/2024 ET)

About International Biotechnology Stock (LON:IBT)

Key Stats

Today's Range
667.12
680
50-Day Range
666
726
52-Week Range
572
734
Volume
116,841 shs
Average Volume
67,767 shs
Market Capitalization
£250.59 million
P/E Ratio
1,412.50
Dividend Yield
4.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

What This Post-Election Shift Means for Your Investments
The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 642 at the beginning of the year. Since then, IBT shares have increased by 5.6% and is now trading at GBX 678.
View the best growth stocks for 2024 here
.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP).

Company Calendar

Ex-Dividend for 8/23 Dividend
7/25/2024
Dividend Payable
8/23/2024
Today
11/21/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£18.19 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£24.14 million
Cash Flow
GBX 4.35 per share
Book Value
GBX 749 per share

Miscellaneous

Free Float
N/A
Market Cap
£250.59 million
Optionable
Not Optionable
Beta
0.21
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (LON:IBT) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners